GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 55 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 20 | -98.2% | 0.00% | -100.0% |
| Q1 2015 | $4,000 | 0.0% | 1,126 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $4,000 | +33.3% | 1,126 | +79.9% | 0.00% | 0.0% |
| Q3 2014 | $3,000 | -66.7% | 626 | 0.0% | 0.00% | -66.7% |
| Q2 2014 | $9,000 | -30.8% | 626 | -25.1% | 0.00% | -40.0% |
| Q1 2014 | $13,000 | +116.7% | 836 | +13.0% | 0.01% | +150.0% |
| Q4 2013 | $6,000 | -14.3% | 740 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $7,000 | – | 740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
| Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
| Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
| WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
| D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
| Virtu Financial LLC | 14,683 | $32,000 | 0.00% |